Efficient tumor targeting by polysaccharide decked polyethylenimine based nanocomposites

Journal of Biomedical Nanotechnology

Volumn 5, Issue 3, 2009, Pages 264-277

  Pathak, Atul ^a   Swami, Archana ^a   Patnaik, Soma ^a   Jain, Sanyog ^b,e   Chuttani, Krishna ^b   Mishra, Anil K ^b   Vyas, Suresh P ^c   Kumar, Pradeep ^a   Gupta, Kailash C ^a,d  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^c DR H S GOUR UNIVERSITY   (India)

^d CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^e NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Cytotoxicity; Hyaluronic acid; In vivo; PEI; Transfection; Tumor targeting

Indexed keywords

HYALURONIC ACID; IN VIVO; PEI; TRANSFECTION; TUMOR TARGETING;

CELL MEMBRANES; CYTOTOXICITY; GENE ENCODING; GENETIC ENGINEERING; HYDROXYLATION; NUCLEIC ACIDS; ORGANIC ACIDS; POLYSACCHARIDES; TUMORS; ZETA POTENTIAL;

NANOCOMPOSITES;

DNA; GREEN FLUORESCENT PROTEIN; HYALURONIC ACID POLYETHYLENIMINE COMPLEX; NANOCOMPOSITE; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEK293; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; EHRLICH ASCITES TUMOR; EMBRYO; EXPERIMENTAL MOUSE; EXPERIMENTAL RABBIT; FEMALE; GAMMA SCINTIGRAPHY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; SOLID TUMOR;

DNA; DRUG DELIVERY SYSTEMS; DURAPATITE; GENE TARGETING; HELA CELLS; HUMANS; KIDNEY; NANOSTRUCTURES; NEOPLASMS; POLYETHYLENEIMINE; POLYSACCHARIDES; TRANSFECTION;

EID: 69249175157     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2009.1031     Document Type: Article

References (50)

1. I. M. Verma and N. Somia, Gene therapy-promises, problems and prospects. Nature 389, 239 (1997).
2. S. Sahoo, S. Parveen, and J. Panda, The present and future of nano- technology in human health care. Nanomed. 3, 20 (2007).
3. El-Aneed, An overview of current delivery systems in cancer gene therapy. J. Control. Release 94, 1 (2004).
4. E. Piskin, S. Dincer, and M. Turk, Gene delivery: Intelligent but just at the beginning. J. Biomater. Sci. Polym. Ed. 15, 1181 (2004).
5. L. Huang and E. Viroonchatapan. Introduction. Edited by L. Huang and M. Wagner, Non-Viral Vector for Gene Therapy. Academic Press, New York (1999), p. 3.
6. C. R. Dass and P. F. M. Choong, Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability. J. Control. Release 113, 155 (2006).
7. X. Zhang and W. T. Godbey, Viral vectors for gene delivery in tissue engineering. Adv. Drug Deliv. Rev. 58, 515 (2006).
8. D. C. Górecki, Prospects and problems of gene therapy: An update. Expert Opin. Enter. Drugs 6, 187 (2001).
9. G. F. Lemkine and B. A. Demeneix, Poly(ethylenimine) for in vivo gene delivery. Curr. Opin. Mol. Ther. 3, 178 (2001).
10. W. T. Godbey, K. K. Wu, and A. G. Mikos, Poly(ethylenimine) and its role in gene delivery. J. Control. Release 60, 149 (1999).
11. J.-P. Behr, The proton sponge: A trick to enter cells the viruses did not exploit. Chimica 51, 34 (1997).
12. A. V. Kabanov, S. V. Vinogradov, Y. G. Suzdaltseva, and V. Y. Alakhov, Water soluble block polycations as carriers for oligonucleotide delivery. Bioconjug. Chem. 6, 639 (1995).
13. S. Katayose and K. Kataoka, Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug. Chem. 8, 702 (1997).
14. Y. H. Choi, F. Liu, J. S. Kim, Y. K. Choi, J. S. Park, and S. W. Kim, Polyethylene glycol-grafted-poly-L-lysine as polymeric gene carrier. J. Control. Release 54, 39 (1998).
15. P. Dubruel and E. H. Schacht, Effect of polyethylene oxide blocs or grafts on the physicochemical properties of poly((2-N- dimethylaminoethyl) methacrylate) DNA complexes. J. Bioact. Compat. Polym. 15, 279 (2000).
16. M. T. Peracchia, C. Vauthier, D. Desmaele, A. Gulik, J. C. Dedieu, M. Demoy, J. d'Angelo, and P. Couvreur, Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm. Res. 15, 550 (1998).
17. G. Kaul and M. Amiji, Long-circulating poly(ethyleneglycol)- modified gelatin nanoparticles for intracellular delivery. Pharm. Res. 19, 1061 (2002).
18. F. F. Davis, The origin of pegnology. Adv. Drug Deliv. Rev. 54, 457 (2002).
19. S. Patnaik, A. Aggarwal, A. Goel, M. Ganguli, N. Saini, Y. Singh, and K. C. Gupta, PEI-alginate nanocomposites as efficient in vitro gene transfection agents. J. Control. Release 114, 398 (2006).
20. S. Kawakami, A. Sato, M. Nishikawa, F. Yamashita, and M. Hashida, Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene. Ther. 7, 292 (2000).
21. G. Kogan, L. Soltés, R. Stern, and P. Gemeiner, Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol. Lett. 29, 17 (2007).
22. T. Asplund and P. Heldin, Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 54, 4516 (1994).
23. D. Naor, S. Nedvetzki, I. Golan, L. Melnik, and Y. Faitelson, CD44 in cancer. Crit. Rev. Clin. Lab. Sci. 39, 527 (2002).
24. C. Wang, A. D. Thor, D. H. Moore, Y. Zhao, R. Kerschmann, R. Stern, P. H. Watson, and E. A. Turley, The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signalling, correlates with over-expression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin. Cancer Res. 4, 567 (1998).
25. U. Günthert, CD44: A multitude of isoforms with diverse functions. Curr. Topics Microbiol. Immunol. 184, 47 (1993).
26. M. Culty, H. A. Nguyen, and C. B. Underhillm, The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell. Biol. 116, 1055 (1992).
27. A. K. Yadav, P. Mishra, and G. P. Agrawal, An insight on hyaluronic acid in drug targeting and drug delivery. J. Drug Target. 16, 91 (2008).
28. X. Q. Zhang, X. L. Wang, P. C. Zhang, Z. L. Liu, R. X. Zhuo, H. Q. Mao, and K. W. Leong, Galactosylated ternary DNA/ polyphospharamidate nanoparticles mediate high gene transfection efficiency in hepatocytes. J. Control. Release 102, 749 (2005).
29. M. Lee, J. W. Nah, Y. Kwon, J. J. Koh, K. S. Ko, and S. W. Kim, Water soluble and low molecular weight chitosan based gene delivery. Pharm. Res. 8, 427 (2001).
30. W. C. Tseng, C. H. Tang, and T. Y. Fang, The role of dextran conjugation in transfection mediated by dextran-grafted polyethylenimine. J. Gene Med. 6, 895 (2004).
31. N. M. Moore, T. R. Barbour, and S. E. Sakiyama-Elbert, Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides. Mol. Pharma. 5, 140 (2008).
32. W. T. Godbey, K. W. Kenneth, and A. G. Mikos, Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA 96, 5177 (1999).
33. S. Mishra, P. Webster, and M. E. Davis, PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. Cell. Biol. 83, 97 (2004).
34. S. Nimesh, A. Goyal, V. Pawar, S. Jayaraman, P. Kumar, R. Chandra, Y. Singh, and K. C. Gupta, Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells. J. Control. Release 110, 457(2006).
35. G. Jiang, K. Park, J. Kim, K. S. Kim, E. J. Oh, H. Kang, S. E. Han, Y. K. Oh, T. G. Park, and S. Kwang Hahn, Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 89, 635 (2008).
36. M. L. Forrest, G. E. Meister, J. T. Koerber, D. W. Pack, Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm. Res. 21, 365 (2004).
37. R. C. Savani, G. Cao, P. M. Pooler, A. Zaman, Z. Zhou, H. M. DeLisser, Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J. Biol. Chem. 276, 36770 (2001).
38. K. Verma and K. Sachin, Novel hydrophilic drug polymer nanoconjugates of Cisplatin showing long blood retention profile: Its release kinetics, cellular uptake and bio-distribution. Curr. Drug Deliv. 5, 120 (2008).
39. M. Ogris, S. Brunner, S. Schuller, R. Kircheis, and E. Wagner, PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6, 595 (1999).
40. A. Swami, R. K. Kurupati, A. Pathak, Y. Singh, P. Kumar, and K. C. Gupta, A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Biochem. Biophy. Res. Comm. 362, 835 (2007).
41. A. K. Yadav. P. Mishra, S. Jain, P. Mishra, A. K. Mishra, and G. P. Agrawal. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. J. Drug Target. 16, 464 (2008).
42. mTc- labeled liposome encapsulated cyclosporine. J. Drug Target. 11, 187 (2003).
43. L. H. Reddy, R. K. Sharma, and R. S. R. Murthy, Enhanced tumour uptake of doxorubicin B loaded poly(butyl cynoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumors. J. Drug Target. 2, 443 (2004).
44. L. H. Reddy, R. K. Sharma, K. Chuttani, A. K. Mishra, and R. S. R. Murthy, Influence of administration route on tumour uptake and biodiatribution of etoposide loaded solid lipid nanoparticles in dalton's lymphoma tumor bearing mice. J. Control. Release 105, 185 (2005).
45. H. Thakkar, R. K. Sharma, A. K. Mishra, K. Chuttani, and R. S. R. Murthy, Efficiency of chitosan microspheres for controlled intra- articular delivery of celecoxib in inflammed joints. J. Pharm. Pharmacol. 56, 1091 (2004).
46. C. L. Williams and G. M. Stancel, The Pharmacological Basis of Therapeutics, 9th edn., edited by A. G. Gilman, L. S. Goodman, T. W. Rail, and F. Murad, Macmillan Publishing Co. New York (1996), p. 1411.
47. B. P. Zeng, S. D. Toole, J. Kinney, and I. Kuo, Stamenkovic. Inhibition of tumor growth in vivo by hyaluronan oligomer. Int. J. Cancer 77, 369 (1998).
48. J. Lesley, V. C. Hascall, M. Tammi, and R. Hyman, Hyaluronan binding by cell surface CD44. J. Biol. Chem. 275, 267 (2000).
49. L. J. Anghileri, In vivo synthesis of acid mucopolysaccharides by Ehrlich ascites tumor cells. J. Cancer Res. Clinical Oncology. 88, 17 (1976).
50. Y. Takei, A. Maruyama, A. Ferdous, Y. Nishimura, S. Kawano, K. Ikejima, S. Okumura, S. Asayama, M. Nogawa, M. Hashimoto, Y. Makino, M. Kinoshita, S. Watanabe, T. Akaike, J. J. Lemasters, and N. Sato, Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan-glycocalyx. FASEB J. 18, 699 (2004).